- Home
- INTS vs PODC Comparison
INTS vs PODC Comparison
Compare INTS & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INTS | PODC |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 131.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | INTS | PODC |
|---|---|---|
| Price | $4.02 | $2.17 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | 18.8K | ★ 60.9K |
| Earning Date | 05-07-2026 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.33 |
| Revenue Next Year | N/A | $19.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $1.50 |
| 52 Week High | $8.06 | $5.20 |
Technical Indicators
Market Signals| Indicator | INTS | PODC |
|---|---|---|
| Relative Strength Index (RSI) | 52.34 | 33.51 |
| Support Level | $3.88 | N/A |
| Resistance Level | $5.09 | $2.58 |
| Average True Range (ATR) | 0.16 | 0.28 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 78.18 | 15.96 |
Price Performance
Historical ComparisonAbout INTS Intensity Therapeutics Inc.
Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more. It generates all its revenue from United States. PodcastOne has built a distribution network reaching over a billion monthly impressions across all channels, including YouTube, Spotify, Apple Podcasts, and iHeartRadio.